Stock Market Today: Indexes Ease After Record Rally, Jobs Data in Focus Amid Geopolitical Tensions
AmazonAmazon(US:AMZN) Stock Market News·2026-01-07 15:07

Market Performance - U.S. equities are showing mixed to slightly lower performance in early trading on January 7th, 2026, following a robust rally that saw major indexes close at record highs [1] - The Dow Jones Industrial Average (DJIA) surged 0.99% to close at an all-time high of 49,462.08, while the S&P 500 (SPX) climbed 0.62% to 6,944.81, and the Nasdaq Composite (IXIC) advanced 0.65% to 23,547.17 [2] - Early Wednesday, S&P 500 futures were down slightly, and the Cboe Volatility Index (VIX) saw a slight increase, indicating a modest uptick in investor apprehension [2] Economic Data - The ADP employment report for December showed 41,000 private sector jobs created, below the consensus estimate of 45,000, indicating a softer labor market [4] - Upcoming economic indicators include the critical December nonfarm payrolls report on January 9th, the Consumer Price Index (CPI) for December on January 13th, and the Producer Price Index (PPI) for November on January 14th [5] Federal Reserve Outlook - The Federal Open Market Committee (FOMC) is scheduled to meet on January 27-28, 2026, with expectations for one or two more interest rate cuts in 2026, possibly in April and September [6] Company-Specific Movements - Energy stocks were impacted by U.S. intervention in Venezuela, with Chevron (CVX) falling more than 4%, while Valero Energy (VLO) climbed 1% due to potential benefits from access to Venezuela's oil supplies [9] - AI-related stocks, including Amazon (AMZN), Micron Technology (MU), and Palantir Technologies (PLTR), saw strong performances, with Micron gaining around 10% and Palantir increasing more than 3% [10] - American International Group, Inc. (AIG) shares plunged 7.5% after CEO Peter Zaffino announced his resignation, while Seagate Technology Holdings plc (STX) shares soared 14% amid a rally in storage stocks [11] - Merck (MRK) completed its acquisition of Cidara Therapeutics, strengthening its respiratory portfolio [12]